InvestSMART

HitIQ Limited (ASX: HIQ) - Announcements

- Current share price for HIQ : $0.008

ASX company news and announcements for HitIQ Limited (HIQ) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All HitIQ Limited (HIQ) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than HitIQ Limited (HIQ), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for HitIQ Limited (HIQ)

Market Cap ($m) Headline Release
date/time+
Price at
release+
Current
price+
Gain/Loss View
$7 Change of Company Secretary 3 Jul 2023 3:00PM $0.018 $0.008 fallen by 55.56%
$7 HITIQ to Receive $1.52m R&D Finance on Forecast R&D Claim 3 Jul 2023 8:18AM $0.018 $0.008 fallen by 55.56%
$7 Application for quotation of securities - HIQ 16 Jun 2023 4:19PM $0.023 $0.008 fallen by 65.22%
$7 Forthcoming Release from Escrow 6 Jun 2023 6:32PM $0.020 $0.008 fallen by 60%
$7 Quarterly Activities/Appendix 4C Cash Flow Report 28 Apr 2023 11:50AM $0.030 $0.008 fallen by 73.33%
$7 HITIQ Secures Sale to Monash University 13 Mar 2023 9:44AM $0.027 $0.008 fallen by 70.37%
$7 Appendix 4D & Half Yearly Financial Statements 27 Feb 2023 8:07PM $0.030 $0.008 fallen by 73.33%
$7 HITIQ's ConneQt Platform to launch with Country Football WA 23 Feb 2023 9:28AM $0.030 $0.008 fallen by 73.33%
$7 HITIQ Expands Partnership with Bupa Dental 14 Feb 2023 8:10AM $0.029 $0.008 fallen by 72.41%
$7 HITIQ secures agreement with University of Canterbury 8 Feb 2023 9:38AM $0.032 $0.008 fallen by 75%
$7 HITIQ Tech to Support Ground-breaking Deakin Uni Research 6 Feb 2023 9:30AM $0.031 $0.008 fallen by 74.19%
$7 HITIQ Signs First Commercial US Collegiate Customer 1 Feb 2023 9:33AM $0.029 $0.008 fallen by 72.41%
$7 Quarterly Activities/Appendix 4C Cash Flow Report 31 Jan 2023 9:30AM $0.028 $0.008 fallen by 71.43%
$7 Receipt of R&D Tax Incentive 16 Jan 2023 9:21AM $0.034 $0.008 fallen by 76.47%
$7 Change of Director's Interest Notice 9 Jan 2023 8:19AM $0.029 $0.008 fallen by 72.41%
$7 Notice under Section 708A(5)(e) of the Corporations Act 2001 23 Dec 2022 8:39AM $0.030 $0.008 fallen by 73.33%
$7 Notification regarding unquoted securities - HIQ 22 Dec 2022 6:20PM $0.030 $0.008 fallen by 73.33%
$7 Application for quotation of securities - HIQ 22 Dec 2022 6:19PM $0.030 $0.008 fallen by 73.33%
$7 HITIQ Partners with United Rugby Championship 22 Dec 2022 9:50AM $0.030 $0.008 fallen by 73.33%
$7 Change of Director Interest Notices x 5 19 Dec 2022 8:18AM $0.034 $0.008 fallen by 76.47%
$7 Notification regarding unquoted securities - HIQ 16 Dec 2022 10:20AM $0.034 $0.008 fallen by 76.47%
$7 Application for quotation of securities - HIQ 16 Dec 2022 10:18AM $0.034 $0.008 fallen by 76.47%
$7 Results of Renounceable Rights Offer 14 Dec 2022 9:28AM $0.034 $0.008 fallen by 76.47%
$7 HIQ to launch Telehealth Concussion Healthcare Platform 13 Dec 2022 9:25AM $0.034 $0.008 fallen by 76.47%
$7 HIQ invited to make submissions to Concussion Senate Enquiry 12 Dec 2022 9:38AM $0.037 $0.008 fallen by 78.38%

326 - 350 of 446 results

Page 14 of 18

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.